Researchers have identified a gene in mosquitoes that helps the insects to fight off infection by the Plasmodium parasite, which causes malaria in humans.

Anopheles mosquitoes transmit the malaria parasite to nearly 550 million people worldwide each year with these cases resulting in more than 2 million deaths annually.

The protective gene was identified in a study conducted by a team of investigators from the Johns Hopkins Bloomberg School of Public Health's Malaria Research Institute, the Imperial College of London and the University of Texas Medical Branch.

The findings are published in the Proceedings of the National Academy of Sciences ( PNAS ).

The malaria-causing Plasmodium has a complex life cycle. Mosquitoes become infected with the parasite when they draw blood from humans who have malaria. As the parasite matures, it moves from the mosquito's midgut to its salivary glands. Once in the salivary glands, the Plasmodium can be injected into another human when the mosquito feeds again.

In the study, the researchers determined that the SPRN6 gene, which is normally switched off in Anopheles stephensi and Anopheles gambiae mosquitoes, is switched on when they are infected with the malaria parasite.

To determine the function of SPRN6, the researchers deactivated the gene in the mosquitoes through a process called RNA interference. They observed that the number of parasites that developed in Anopheles stephensi mosquitoes increased three-fold when the gene was knocked out. In Anopheles gambiae mosquitoes, removing the SPRN6 gene delayed the process of parasite lysis, whereby the mosquito rids itself of the parasite.

" This study furthers our knowledge of the malaria-parasite lysis in mosquitoes. It may help provide better tools for controlling the disease in the future," said lead author Eappen G. Abraham, at the Bloomberg School of Public Health.

" These results provided new insights into how the mosquito defends itself from the malaria parasite. More research is needed, but we plan to apply this knowledge in the development of new approaches to control the disease," said co-author Marcelo Jacobs-Lorena, at the Bloomberg School of Public Health.

Abraham and Jacobs-Lorena are developing a transgenic mosquito in which the SPRN6 gene is permanently switched on, in an effort to create a mosquito that would be immune to the Plasmodium parasite. They believe that such a mosquito could help disrupt the transmission of malaria to humans.

Source: Johns Hopkins University Bloomberg School of Public Health, 2005


XagenaMedicine2005